JP2004519488A5 - - Google Patents

Download PDF

Info

Publication number
JP2004519488A5
JP2004519488A5 JP2002571051A JP2002571051A JP2004519488A5 JP 2004519488 A5 JP2004519488 A5 JP 2004519488A5 JP 2002571051 A JP2002571051 A JP 2002571051A JP 2002571051 A JP2002571051 A JP 2002571051A JP 2004519488 A5 JP2004519488 A5 JP 2004519488A5
Authority
JP
Japan
Prior art keywords
composition
nicotinic acid
acid ester
subject
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002571051A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004519488A (ja
JP5057353B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/007256 external-priority patent/WO2002072092A1/en
Publication of JP2004519488A publication Critical patent/JP2004519488A/ja
Publication of JP2004519488A5 publication Critical patent/JP2004519488A5/ja
Application granted granted Critical
Publication of JP5057353B2 publication Critical patent/JP5057353B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002571051A 2001-03-08 2002-03-08 ニコチン酸化合物を使用するレプチンレベル増大のための方法 Expired - Fee Related JP5057353B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27434901P 2001-03-08 2001-03-08
US60/274,349 2001-03-08
PCT/US2002/007256 WO2002072092A1 (en) 2001-03-08 2002-03-08 Method for increasing leptin levels using nicotinic acid compounds

Publications (3)

Publication Number Publication Date
JP2004519488A JP2004519488A (ja) 2004-07-02
JP2004519488A5 true JP2004519488A5 (enExample) 2005-12-22
JP5057353B2 JP5057353B2 (ja) 2012-10-24

Family

ID=23047813

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002571051A Expired - Fee Related JP5057353B2 (ja) 2001-03-08 2002-03-08 ニコチン酸化合物を使用するレプチンレベル増大のための方法

Country Status (12)

Country Link
US (2) US6750234B2 (enExample)
EP (1) EP1365762B1 (enExample)
JP (1) JP5057353B2 (enExample)
CN (1) CN1265792C (enExample)
AT (1) ATE409037T1 (enExample)
CA (1) CA2437844C (enExample)
DE (1) DE60229041D1 (enExample)
DK (1) DK1365762T3 (enExample)
ES (1) ES2315358T3 (enExample)
MX (1) MXPA03008096A (enExample)
PT (1) PT1365762E (enExample)
WO (1) WO2002072092A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
AU8436401A (en) 2000-07-31 2002-02-13 Univ Bar Ilan Methods and pharmaceutical compositions for healing wounds
WO2002072092A1 (en) * 2001-03-08 2002-09-19 University Of Kentucky Method for increasing leptin levels using nicotinic acid compounds
BR0315942A (pt) 2002-11-27 2005-10-04 Dmi Biosciences Inc Tratamento de doenças e condições mediadas pelo aumento de fosforilação
US7736636B2 (en) * 2003-02-12 2010-06-15 Shaker Mousa Method for treating occlusive vascular diseases & wound healing
US7218948B2 (en) 2003-02-24 2007-05-15 Qualcomm Incorporated Method of transmitting pilot tones in a multi-sector cell, including null pilot tones, for generating channel quality indicators
US9544860B2 (en) 2003-02-24 2017-01-10 Qualcomm Incorporated Pilot signals for use in multi-sector cells
US8811348B2 (en) 2003-02-24 2014-08-19 Qualcomm Incorporated Methods and apparatus for generating, communicating, and/or using information relating to self-noise
ATE529125T1 (de) 2003-08-07 2011-11-15 Healor Ltd Pharmazeutische zusammensetzungen und verfahren zur beschleunigung der wundheilung
US8969291B2 (en) 2004-10-08 2015-03-03 Enzo Therapeutics, Inc. Methods for decreasing leptin levels or activity for treating inflammation
US8503938B2 (en) 2004-10-14 2013-08-06 Qualcomm Incorporated Methods and apparatus for determining, communicating and using information including loading factors which can be used for interference control purposes
BRPI0516493A (pt) 2004-10-14 2008-09-09 Qualcomm Flarion Tech métodos e aparelho para determinar, comunicar e utilizar informações que podem ser usadas para fins de controle de interferência
JP2006253769A (ja) * 2005-03-08 2006-09-21 National Institute Of Advanced Industrial & Technology 情報処理システムおよび方法
HUE034582T2 (en) * 2005-06-24 2018-02-28 Arizona Board Of Regents Acting On Behalf Of The Univ Of Arizona A method of treating hair growth disorders, such as female alopecia, and compositions for use therein
EP2452691A3 (en) 2005-08-29 2012-09-05 HealOr Ltd. Methods and compositions for prevention of diabetic and aged skin
US20070066512A1 (en) * 2005-09-12 2007-03-22 Dominique Verhelle Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels
US8989084B2 (en) 2005-10-14 2015-03-24 Qualcomm Incorporated Methods and apparatus for broadcasting loading information corresponding to neighboring base stations
US9191840B2 (en) 2005-10-14 2015-11-17 Qualcomm Incorporated Methods and apparatus for determining, communicating and using information which can be used for interference control
US9119220B2 (en) 2005-12-22 2015-08-25 Qualcomm Incorporated Methods and apparatus for communicating backlog related information
US9148795B2 (en) 2005-12-22 2015-09-29 Qualcomm Incorporated Methods and apparatus for flexible reporting of control information
US7801589B2 (en) 2005-12-22 2010-09-21 Olympus Corporation In-vivo examination method and in-vivo examination apparatus
US9473265B2 (en) 2005-12-22 2016-10-18 Qualcomm Incorporated Methods and apparatus for communicating information utilizing a plurality of dictionaries
US9451491B2 (en) 2005-12-22 2016-09-20 Qualcomm Incorporated Methods and apparatus relating to generating and transmitting initial and additional control information report sets in a wireless system
US9338767B2 (en) 2005-12-22 2016-05-10 Qualcomm Incorporated Methods and apparatus of implementing and/or using a dedicated control channel
US9137072B2 (en) 2005-12-22 2015-09-15 Qualcomm Incorporated Methods and apparatus for communicating control information
US8514771B2 (en) 2005-12-22 2013-08-20 Qualcomm Incorporated Methods and apparatus for communicating and/or using transmission power information
US9125093B2 (en) 2005-12-22 2015-09-01 Qualcomm Incorporated Methods and apparatus related to custom control channel reporting formats
US9125092B2 (en) 2005-12-22 2015-09-01 Qualcomm Incorporated Methods and apparatus for reporting and/or using control information
US9572179B2 (en) 2005-12-22 2017-02-14 Qualcomm Incorporated Methods and apparatus for communicating transmission backlog information
US8437251B2 (en) 2005-12-22 2013-05-07 Qualcomm Incorporated Methods and apparatus for communicating transmission backlog information
US20070253449A1 (en) 2005-12-22 2007-11-01 Arnab Das Methods and apparatus related to determining, communicating, and/or using delay information
US20070243882A1 (en) 2006-04-12 2007-10-18 Qualcomm Incorporated Method and apparatus for locating a wireless local area network associated with a wireless wide area network
JP5051471B2 (ja) * 2006-08-31 2012-10-17 智 板見 休止期脱毛症治療剤
AU2008219633B2 (en) * 2007-02-28 2011-05-26 Arizona Board Of Regents On Behalf Of The University Of Arizona Method for alleviating side effects of retinoic acid therapy and/or improving efficacy without interfering with efficacy
AU2011204425A1 (en) 2010-01-11 2012-08-02 Healor Ltd. Method for treatment of inflammatory disease and disorder
JP7229772B2 (ja) * 2016-04-22 2023-02-28 ジェイシー(ウーシー) カンパニー,インコーポレーテッド イソチオシアネート系化合物の使用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
DE3110611A1 (de) * 1981-03-18 1982-10-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen "mitogene der leukozyten und des entzuendungsgewebes:natuerliche leukopoetine zur selektiven anregung der teilung und differenzierung von leukozyten"
GB8330969D0 (en) * 1983-11-21 1983-12-29 Wellcome Found Promoting healing
DE3570598D1 (en) * 1984-11-15 1989-07-06 Nitto Denko Corp Composition for percutaneous administration
US4965252A (en) * 1988-06-28 1990-10-23 Hauser-Kuhrts, Inc. Cholesterol-lowering combination compositions of guar gum and niacin
EP0573568B1 (en) * 1991-03-01 2001-01-24 University Of Florida Research Foundation, Inc. Use of nicotinic analogs for treatment of degenerative diseases of the nervous system
US5240945A (en) * 1992-02-18 1993-08-31 Warshaw Thelma G Method and compositions for treating acne
US5496827A (en) * 1994-07-15 1996-03-05 Patrick; Jay Compositions for the transdermal delivery of nutrients
US5612382A (en) * 1994-07-15 1997-03-18 Frances B. Fike Composition for percutaneous absorption of pharmaceutically active ingredients
WO1996029405A2 (en) * 1995-03-20 1996-09-26 Ligand Pharmaceuticals Incorporated MODULATORS OF ob GENE AND SCREENING METHODS THEREFOR
JP4553166B2 (ja) * 1995-05-01 2010-09-29 スカリスタ リミテッド ニコチン酸エステルおよびそれを含む薬剤組成物
US20040102358A1 (en) * 1997-05-19 2004-05-27 Scivoletto Rosemarie Composition for treating skin conditions
AU4672199A (en) * 1998-05-20 1999-12-06 Yale University Modulation of angiogenesis and wound healing
NZ511708A (en) * 1998-12-01 2003-12-19 Univ Kentucky Res Found A method for enhancing protective cellular responses to genotoxic stress in skin
IT1306141B1 (it) * 1999-05-17 2001-05-30 Giampiero Valletta Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.
US6326034B1 (en) * 1999-12-22 2001-12-04 Natural Compounds Ltd Natural extracted and synthetic antioxidant compositions
WO2002072092A1 (en) * 2001-03-08 2002-09-19 University Of Kentucky Method for increasing leptin levels using nicotinic acid compounds

Similar Documents

Publication Publication Date Title
JP2004519488A5 (enExample)
NO20045072L (no) Tablett med hoyt medikamentinnhold
LUC00155I1 (enExample)
JP2008513467A5 (enExample)
RU2003121236A (ru) Арилированные амиды фуран- и тиофенкарбоновых кислот с блокирующим калиевый канал действием
WO2007003521A3 (en) Pyridazine derivatives as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
MY138941A (en) Aryl-pyridine derivatives
JP2005508371A5 (enExample)
JP2003520232A5 (enExample)
WO2008148868A8 (en) Piperidine/piperazine derivatives
MY125099A (en) Comminuted form of (s)-2-ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) penyl] propanoic acid
JP2004002446A5 (enExample)
JP2003508467A5 (enExample)
JP2001513506A5 (enExample)
TW200616958A (en) New alkyl-pyridines as 11-beta inhibitors for diabetes
MXPA02012038A (es) Analogos heterociclicos novedosos de compuestos de difeniletileno.
JP2009515927A5 (enExample)
ITTO920303A1 (it) Composizione farmaceutica antiinfiammatoria
JP2004026743A5 (enExample)
JP2012097036A5 (enExample)
PE20070828A1 (es) Composicion farmaceutica que contiene una sal de glicopirronio
JP2002179518A5 (enExample)
JP2008503574A5 (enExample)
JP2010527369A5 (enExample)
BRPI0506710A (pt) composições farmacêuticas de liberação controlada